Construction of cat coronary arteries by synthetic thromboxane A2 and its antagonism
- 1 June 1987
- journal article
- research article
- Published by Elsevier in Prostaglandins
- Vol. 33 (6) , 777-782
- https://doi.org/10.1016/0090-6980(87)90105-5
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Synthesis and structure of the platelet aggregation factor thromboxane A2Nature, 1985
- BENEFICIAL-EFFECTS OF A NEW POTENT AND SPECIFIC THROMBOXANE RECEPTOR ANTAGONIST (SQ-29,548) INVITRO AND INVIVO1985
- The pharmacological profile of the thromboxane A2 antagonist BM 13.177. A new anti-platelet and anti-thrombotic drugThrombosis Research, 1984
- Investigations on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human plateletsThrombosis Research, 1984
- Responsiveness of platelets and coronary arteries from different species to synthetic thromboxane and prostaglandin endoperoxide analoguesBritish Journal of Pharmacology, 1983
- Dissociation of vasoconstrictor and platelet aggregatory activities of thromboxane by carbocyclic thromboxane A2, a stable analog of thromboxane A2.Proceedings of the National Academy of Sciences, 1980
- Cardiac and Coronary Prostaglandin Synthesis and FunctionNew England Journal of Medicine, 1978
- Thromboxanes: Selective Biosynthesis and Distinct Biological PropertiesScience, 1976
- Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxidesNature, 1976